ILMN

Illumina, Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$209.55

Price (1 Year)

$278.17 $116.81

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %9 / %30
Non-compliant assets / Total market cap %5.1 / %30
Non-compliant revenue / Total income %0.9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest.

Website

Analysis (Turkish): ILMN Hissesi Caiz mi, Helal mi? Illumina, Inc. Katılım Analizi